Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

EU Commission's approval of key Roundup ingredient "flew in the face of a censure of the commission," environmentalists say. (Photo: Mike Mozart/Flickr/cc.)

EU Moves to Reapprove Monsanto's Toxic Glyphosate

Europe plans to re-approve "probable carcinogen" for another 15 years—just as traces of the toxin are discovered in major brands of feminine products

Nika Knight Beauchamp

In defiance of popular sentiment and scientific warnings, the European Commission plans to re-approve the use of controversial weedkiller glyphosate, a "probable carcinogen" according to the WHO, for another 15 years, according to a draft regulation (pdf) obtained by Bloomberg BNA.

The herbicide, the key ingredient in Monsanto's Roundup, is already so widely used in Europe that two-thirds of bread loaves sold in Britain contain residue from the toxic chemical, the Guardian reported in 2014.

The announcement of the European Commission's plans, to be voted on at a meeting on March 7th-8th, came on the heels of a report published on Tuesday by the French magazine 60 Millions de Consommateurs, which found traces of glyphosate and other industrial toxins in 5 out of 11 brands of feminine hygiene products.

The Roundup chemical was even discovered in so-called "organic" panty liners made by French feminine product company Organyce. The company has pulled 3,100 boxes of its products from stores in France and Canada "as a precautionary measure" after internal tests confirmed the herbicide's presence in its products, an Organyce spokesperson told the Independent.

The European Commission's plans to approve the toxic chemical followed the EU ombudsman's strong critique (pdf) of the body's regulatory process, which was published just this week. The commission's drafted regulation "flew in the face of a censure of the commission by the EU ombudsman," environmentalists told the Guardian.

The ombudsman, Emily O'Reilly, found that the commission may have been too "lenient in its practices," risking the health of humans, animals, and the planet.

Bloomberg BNA reports:

In a Feb. 22 decision, the Ombudsman said that in some cases the commission granted pesticide approvals through a so-called confirmatory data procedure, under which applicants were asked to provide additional risk assessments and other data on the potential risks of substances, but the commission allowed the approvals anyway while waiting for the additional information.

The Ombudsman said a 1991 EU law on pesticide authorizations (Directive 91/414/EEC) “does not contain an express legal basis” for use of the confirmatory data procedure and by using the procedure the commission may have acted in a way that was “unlawful and contrary to the principles of good administration.”

A 2009 EU regulation on pesticide authorizations (Regulation 1107/2009) that replaced the 1991 directive did include a firmer legal base for the procedure, but the procedure should be used only in "exceptional cases" when likelihood of a pesticide evaluation being changed was "minor," the Ombudsman said.

Pesticide Action Network (PAN), a coalition of over 600 NGOs and institutions around the world working to replace harmful pesticides with ecological alternatives, brought the original complaint about the commission's approval process to the ombudsman.

In a press release on Tuesday, PAN Europe's chemicals coordinator argued that the commission had "let the interests of industry and farmers prevail over the interests of the public in allowing harmful pesticides on the market with data gaps and high risks. This structural violation of the rules implies that the pesticides currently on the market are not safe."

Martin Häusling, the agriculture and public health spokesman for The Greens/European Free Alliance, argued that "[g]iven the serious health concerns and conflicting scientific advice, the commission should be respecting its duty to apply the precautionary principle and not steamrolling through approval of this highly controversial substance."

The commission has agreed to submit a report to demonstrate that it has taken action to make the ombudsman's requested fixes to its approval process in two years—but with its proposed new 15-year lease, glyphosate would not be up for regulatory consideration again until 2031.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Senate Barely Approves Scaled Back Legislation on Climate, Taxes, Healthcare

But thanks to Senator Kyrsten Sinema (D-AZ), there was a huge, last-minute win for the private equity and hedge fund industries

Common Dreams staff ·


'What the Hell is Wrong With Them': GOP Senators Kill $35 Cap on Insulin

'Republicans told millions of Americans who use insulin to go to hell.'

Common Dreams staff ·


World Faces 'Loaded Gun' on Hiroshima's 77th Anniversary

“We must ask: What have we learned from the mushroom cloud that swelled above this city?”

Common Dreams staff ·


'Extremely Concerned': Shelling of Europe's Biggest Nuclear Power Plant More Worrying Than Chernobyl

Ukraine said parts of the facility were "seriously damaged" by Russian military strikes.

Common Dreams staff ·


'Backsliding on Democracy': Indiana Governor Signs Extreme Abortion Ban Bill

'The extremist lawmakers who forced this bill through a special session clearly could not care less about what their constituents want or need.'

Common Dreams staff ·

Common Dreams Logo